94443 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
Sub-classes:ARYL HYDROCARBON RECEPTOR ACTIVATORS
#2METHOD FOR ARYL DEBROMINATION AND ACYLATION OF BROMINATED BENZO-FUSED NITROGEN HETEROCYCLE
#3COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS
#4OCT4 HIGH-SELECTIVITY ACTIVATOR
#5Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune Disorders
#6PROCESS FOR PREPARATION OF SELUMETINIB AND SALTS THEREOF
#7PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#8HSD17B13 INHIBITORS AND USES THEREOF
#9ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE
#10MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
#11ALKYLAMINE OR HETEROALKYLAMINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#12COMPOUND AND USE THEREOF IN ORGANIC OPTOELECTRONIC DEVICE
#13PHARMACEUTICAL COMPOSITION
#14Pharmaceutical composition
#15CRYSTAL FORMS A, B, C, D, E, F AND G OF SELUMETINIB SULFATE AND PREPARATION METHODS THEREOF
#16Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune Disorders
#17ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION
#18PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#19ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE
#20Inhibitors of NLRP3 inflammasome
#21INHIBITORS OF NLRP3 INFLAMMASOME
#22INHIBITORS OF NLRP3 INFLAMMASOME
#23PHARMACEUTICAL COMPOSITION
#24Pharmaceutical composition
#25INHIBITORS OF NLRP3 INFLAMMASOME
#26PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#27Modulators of mas-related G-protein receptor X2 and related products and methods
#28SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28
#29Compositions and methods for reducing immune intolerance and treating autoimmune disorders
#30HYDROXAMIC ACID-CONTAINING COMPOUND, AND PREPARATION METHOD AND USE THEREOF
#31Compound and organic light-emitting device comprising same
#32SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
#33Benzimidazole Derivatives
#34Acid addition salts of benzimidazole derivative
#35Substituted benzimidazole compound and composition comprising same
#36NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF
#37Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof
#38Compositions and methods for reducing immune intolerance and treating autoimmune disorders
#39NUCLEAR RECEPTOR MODULATORS
#40Bicyclic compounds
#41γ-diketones as Wnt/β-catenin signaling pathway activators
#42Inhibitors of NLRP3 inflammasome
#43EBNA1 inhibitors and their method of use
#44Heterocyclic compound
#45Modulators of Mas-related G-protein receptor X2 and related products and methods
#46Inhibitors of NLRP3 inflammasome
#47Aromatic sulfonamide derivatives
#48HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
#49ARYL HYDROCARBON RECEPTOR ACTIVATORS
#50NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME
#51INHIBITORS OF SARM1
#52Pharmaceutical composition
#53Compounds for modulating mitochondrial function
#54Bicyclic compounds and their use in the treatment of cancer
#55CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF
#56Benzimidazol derivatives for treating filovirus infection
#57Acid addition salts of benzimidazole derivative
#58TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#59Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#60VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF
#61COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
#62Pyruvate kinase activators for use in therapy
#63Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof
#64Compositions for the treatment of pulmonary fibrosis
#65NUCLEAR RECEPTOR MODULATORS
#66Organic electroluminescence device and polycyclic compound for organic electroluminescence device
#67Synthetic nicotine composition
#68Bicyclic compounds and their use in the treatment of cancer
#69Compounds for modulating mitochondrial function
#70Non-coordinating anion type benzimidazolium activators
#71Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
#72Preparation method for zeolitic imidazolate frameworks
#73PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
#74Heterocyclic compound
#75Gamma-diketones as wnt/β-catenin signaling pathway activators
#76Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one
#77Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
#78EBNA1 inhibitors and their method of use
#79PHARMACEUTICAL COMPOSITION
#80Preparation of and formulation comprising a MEK inhibitor
#81TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#82BICYCLIC UREA COMPOUNDS AND THEIR USE AS SOLVENT
#83Compounds for modulating mitochondrial function
#84Bicyclic heterocyclic derivatives as MNK1 and MNK2 modulators and uses thereof
#85Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
#86Heterocyclic compounds for the treatment of arenavirus
#87Benzimidazole derivatives: preparation and pharmaceutical applications
#88Compositions for the treatment of pulmonary fibrosis
#89Glucosylceramide synthase inhibitors for the treatment of diseases
#90Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#91Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one
#92Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#93Aromatic sulfonamide derivatives
#94Manganese (III) catalyzed C—H aminations
#95Small molecule inhibitors of DYRK1A and uses thereof
#96γ-diketones as Wnt/β-catenin signaling pathway activators
#97Compound and organic light-emitting device comprising same
#98NUCLEAR RECEPTOR MODULATORS
#99Urea compound, preparation method therefor and medical use thereof
#100PHARMACEUTICAL COMPOSITION
#101SHIP1 MODULATORS AND METHODS RELATED THERETO
#102Microbiocidal phenylamidine derivatives
#103AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS
#104Pyruvate kinase activators for use in therapy
#105TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#106Organic light-emitting device
#107Preparation of and formulation comprising a MEK inhibitor
#108APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#109Heterocyclic compounds and uses thereof
#110Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
#111BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
#112Benzimidazole compound and medical use thereof
#113Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one
#114Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#115EBNA1 inhibitors and their method of use
#116Nonaqueous electrolyte and nonaqueous secondary battery
#117Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof
#118Compounds for modulating mitochondrial function
#119Benzimidazole derivatives: preparation and pharmaceutical applications
#120γ-diketones as Wnt/β-catenin signaling pathway activators
#121TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#122Selective HDAC3 inhibitors
#123Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#124Benzimidazole derivatives as kinase inhibitors
#125Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
#126Antiviral drugs for treatment of arenavirus infection
#127NOVEL MOLECULES THAT SELECTIVELY INHIBIT HISTONE DEACETYLASE 6 RELATIVE TO HISTONE DEACETYLASE
#128Substituted Aromatic Sulfur Compounds and Methods of Their Use
#129Method for producing optically active carboxylic acid ester
#130Azaspiro derivatives as TRPM8 antagonists
#131Substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase
#132Nuclear receptor modulators
#133Benzimidazole derivatives as selective blockers of persistent sodium current
#134Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
#135Compound and epoxy resin composition containing same
#136Benzimidazole and imadazopyridine carboximidamide compounds
#137GLP-1 receptor stabilizers and modulators
#138EBNA1 inhibitors and their method of use
#139Benzimidazole derivatives: preparation and pharmaceutical applications
#140Onium salt compound, resist composition, and pattern forming process
#141Glucosylceramide synthase inhibitors for the treatment of diseases
#142Store overload-induced calcium release inhibitors and methods for producing and using the same
#143Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#144Preparation of and formulation comprising a MEK inhibitor
#145Preparation of and formulation comprising a MEK inhibitor
#146Preparation of and formulation comprising a MEK inhibitor
#147Pesticide compounds
#1481,3-diaminocyclopentane carboxamide derivatives
#149Bilaterally-substituted tricyclic compounds for the treatment of human immunodeficiency virus type-1 (HIV-1) infection and other diseases
#150Pyruvate kinase activators for use in therapy
#151Compound, and light-emitting device and electronic device including same
#152Heterocyclic derivative and pharmaceutical drug
#153Inhibitors
#154Histone deacetylase inhibitors and compositions and methods of use thereof
#155Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
#156Hydrogen sulfate salt
#157Compound, light emitting material, and organic light emitting device
#158COMPOUNDS AND THERAPEUTIC USES THEREOF
#159Benzimidazole derivatives as Kinase Inhibitors
#160Substituted cinnamic acid amides for treating pain
#161Crystal containing unsaturated carboxylic acid amide compound and method for producing same
#162Selective HDAC3 inhibitors
#163Tetralin and indane derivatives and uses thereof
#164Hematopoietic growth factor mimetic small molecule compounds and their uses
#165ENOYL REDUCTASE INHIBITORS WITH ANTIBACTERIAL ACTIVITY
#166Ring-fused compound
#167Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#168Compound and organic electroluminescent device comprising the same
#169Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation
#170Benzimidazole derivatives: preparation and pharmaceutical applications
#171Method for preparing nitrogen compounds
#172N-biphenylmethylbenzimidazole modulators of PPARG
#173Modulators of the relaxin receptor 1
#174Benzimidazole compounds and their use as chromatographic ligands
#175Indole, indoline derivatives, compositions comprising them and uses thereof
#176Antiviral drugs for treatment of arenavirus infection
#177N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides
#178BENZIMIDAZOLE DERIVATIVES AS SELECTIVE BLOCKERS OF PERSISTENT SODIUM CURRENT
#179Bicyclic heterocyclic derivatives as MNK1 and MNK2 modulators and uses thereof
#180CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof
#181GLP-1 receptor stabilizers and modulators
#182EP1 receptor ligands
#183Prodrugs of non-steroid anti-inflammatory agents (NSAIDS)
#184Organic electroluminescent element, and light emitting device, display device and lighting device each using organic electroluminescent element
#185Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
#186N-BENZYLBENZIMIDAZOLE MODULATORS OF PPARG
#187Selective HDAC3 inhibitors
#188γ-diketones as WNT/β-catenin signaling pathway activators
#189Selective HDAC3 inhibitors
#190SUBSTITUTED HYDOXAMIC ACIDS AND USES THEREOF
#191Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#192Heterocyclic derivative and pharmaceutical drug
#193Pyruvate kinase activators for use in therapy
#194Preparation of and formulation comprising a MEK inhibitor
#195HDAC inhibitors and therapeutic methods using the same
#196Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
#197Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#198Antimicrobial and radioprotective compounds
#199Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#200Inhibitors
#201Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#202Ring-fused compound
#203Benzimidazole derivatives: preparation and pharmaceutical applications
#204COMPOUNDS AND THERAPEUTIC USES THEREOF
#205Organic electroluminescent element
#206Compound for organic light-emitting diode and organic light-emitting diode including the same
#207Processes for preparing benzimidazole compounds
#208Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition
#209Benzimidazole derivatives as selective blockers of persistent sodium current
#210Arylsulfonamide based matrix metalloprotease inhibitors
#211NOVEL YELLOW PIGMENT COMPOSITION, AND METHOD FOR PRODUCING YELLOW PIGMENT MICROPARTICLES
#212Analogues for the treatment or prevention of flavivirus infections
#213Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#214Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#215[5, 6] HETEROCYCLIC COMPOUND
#216COMPOUNDS AND THERAPEUTIC USES THEREOF
#217Amino alcohol derivatives and their therapeutic activities
#218Hematopoietic growth factor mimetic small molecule compounds and their uses
#219CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#220Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
#221Methods and compositions of treating a flaviviridae family viral infection
#222Arylsulfonamide based matrix metalloprotease inhibitors
#223Hydrogen sulfate salt
#224N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides
#225Antimicrobial and radioprotective compounds
#226PHENYLACETAMIDES SUITABLE AS PROTEIN KINASE INHIBITORS
#227SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS
#228Screening method for enzyme inhibitors
#229Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#230Substituted hydrazide compounds and use thereof
#231PHARMACEUTICAL COMPOSITION 271
#232Tetralin and indane derivatives and uses thereof
#233Antiviral drugs for treatment of arenavirus infection
#234Hydroxamates as therapeutic agents
#235Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#236Substituted imidazole derivatives and methods of use thereof for treating cancer
#237SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#238Benzimidazole compounds
#239Process for preparing benzimidazole compounds
#240Compounds for treating cancer
#241PHARMACEUTICAL USE OF SUBSTITUTED AMIDES
#242COMPOUNDS FOR STEM CELL DIFFERENTIATION
#243DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#244Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
#245Stimulus-responsive apta chelamers
#246PDE-10 inhibitors
#247Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
#248Anti-viral drugs for treatment of arenavirus infection
#249Substituted benzimidazoles
#250Heterocyclic amide compounds useful as kinase inhibitors
#251Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
#252Benzimidazole derivatives
#253Method and system for hydrogen evolution and storage
#254Benzimidazole derivatives and their use for modulating the GABAreceptor complex
#255BENZIMIDAZOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOF
#256Inhibitors
#257Selective inhibitors of histone deacetylase
#258PROLYL HYDROXYLASE INHIBITORS
#259Benzimidazole Compounds
#260Hydroxamates as therapeutic agents
#261Arylsulfonamide-based matrix metalloprotease inhibitors
#262METHOD FOR PRODUCING COMPOUND HAVING DEUTERATED AROMATIC RING OR HETEROCYCLIC RING
#263Methyl-benzimidazole derivatives
#264Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors
#265N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides
#266Compounds for inflammation and immune-related uses
#267Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#268Catalysts containing N-heterocyclic carbenes for enantioselective synthesis
#269Antimicrobial and radioprotective compounds
#2704-heteroaryl-substituted phenoxyphenylacetic acid derivatives
#271CMP porous pad with particles in a polymeric matrix
#272Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
#273N3 alkylated benzimidazole derivatives as MEK inhibitors
#274N3 alkylated benzimidazole derivatives as MEK inhibitors
#275N3 alkylated benzimidazole derivatives as MEK inhibitors
#276Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
#277Benzimidazole derivatives: preparation and pharmaceutical applications
#278Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
#279Substituted piperazines
#280TRANSITION METAL COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME
#281Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
#282EPHA4 RTK INHIBITORS FOR TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISORDERS AND CANCER
#283BENZIMIDAZOLE DERIVATIVE
#284Benzimidazole compounds and their use as anticancer agents
#285APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#286Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells
#287ESTER COMPOUND AND MEDICAL USE THEREOF
#288Process for preparing benzimidazole compounds
#289SNAR process for preparing benzimidazole compounds
#290Tetralin and indane derivatives and uses thereof
#291Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
#292Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
#293Insecticidal compounds
#294Phenylacetamides being FLT3 inhibitors
#295Certain Chemical Entities, Compositions, and Methods
#296DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#297Substituted arylalkanoic acid derivatives and use thereof
#298BENZIMIDAZOLE COMPOUND-CONTAINING COMPOSITION AND LIGHT-EMITTING DEVICE USING THE COMPOSITION
#299NOVEL HYDROGEN SULFATE SALT
#300Method of screening for inhibitors of glutaminyl cyclase activity